Owlet, Inc. (NYSE: OWLT) is a Healthcare company (Medical - Devices) with a market capitalization of $101M. The Maz Rating grades it against the other companies in its sector.
Owlet, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.44, Owlet, Inc. trades at 0.9x sales and 3.8x book value. Over the last twelve months it generated about $113M of revenue and a net loss of $17M. It runs a gross margin of 55.6%, an operating margin of -6.6% and a net margin of -10.3%. It shows return on equity of -34.3%, return on invested capital of -13.6% and a free cash flow yield of -5.2%. On the balance sheet: a debt-to-equity ratio of 0.42 and a current ratio of 1.91. Over the past 52 weeks the share price ranged from $2.75 to $16.94, with a beta of 1.91.
Owlet, Inc. does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 4 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.